EPIC Program Annual Data Tables 2005-2006: Table VIII

Table VIII
Twenty Most Frequently Purchased Drugs*
Rank by Number
of Claims
Drug and StrengthDrug
Type**
Number
of Claims
EPIC
Payments
Rank by
Payment
Top 20 Totals2,286,394 $172,549,047
Percent of Top 20 Drugs to Total Paid Claims 19.85% 21.22%
1 FUROSEMIDE (40 MG) Gen 171,779 $733,478 195
2 LIPITOR (10 MG) SS 166,260 $17,192,756 5
3 PLAVIX (75 MG) SS 161,754 $28,653,466 1
4 FOSAMAX (70 MG) SS 147,244 $14,827,200 7
5 NORVASC (5 MG) SS 136,209 $8,566,206 12
6 HYDROCHLOROTHIAZIDE (25 MG) Gen 130,927 $430,984 310
7 METOPROLOL TARTRATE (50 MG) Gen 121,336 $495,058 270
8 LIPITOR (20 MG) SS 116,196 $17,619,069 4
9 FUROSEMIDE (20 MG) Gen 113,674 $438,058 303
10 TOPROL XL (50 MG) SS 112,041 $3,713,908 42
11 PROTONIX (40 MG) SS 106,727 $16,640,035 6
12 NORVASC (10 MG) SS 103,534 $8,527,368 13
13 ATENOLOL (50 MG) Gen 100,342 $572,003 238
14 NEXIUM (40 MG) SS 97,702 $21,126,918 2
15 METFORMIN HCL (500 MG) Gen 95,946 $1,644,686 102
16 PREVACID (30 MG) SS 87,638 $18,284,531 3
17 ACTONEL (35 MG) SS 84,069 $7,994,458 16
18 FOLIC ACID (1 MG) Gen 78,198 $560,138 245
19 XALATAN (0.005%) SS 77,833 $4,083,814 36
20 ATENOLOL (25 MG) Gen 76,985 $444,913 298

* Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October 1, 2005-September 30, 2006) as well as the percentage of the totals they represent for the year.

** Drug Type values are Gen='Generic' and SS='Sole Source'.